Total Payments
$175,979
2024 Payments
$2,548
Companies
7
Transactions
141
Payment Breakdown by Category
Consulting$134,160 (76.2%)
Travel$22,231 (12.6%)
Other$15,802 (9.0%)
Food & Beverage$2,067 (1.2%)
Research$1,719 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $134,160 | 53 | 76.2% |
| Travel and Lodging | $22,231 | 30 | 12.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,802 | 11 | 9.0% |
| Food and Beverage | $2,067 | 44 | 1.2% |
| Unspecified | $1,719 | 3 | 1.0% |
Payments by Type
General
$174,259
138 transactions
Research
$1,719
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $134,726 | 130 | $0 (2024) |
| Chiesi USA, Inc. | $27,120 | 2 | $0 (2022) |
| SANOFI US SERVICES INC. | $6,872 | 4 | $0 (2020) |
| Amicus Therapeutics, Inc. | $5,025 | 1 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $1,297 | 2 | $0 (2021) |
| Novo Nordisk Inc | $540.00 | 1 | $0 (2019) |
| BIOVERATIV THERAPEUTICS INC. | $400.00 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,548 | 1 | GENZYME CORPORATION ($2,548) |
| 2023 | $3,050 | 2 | GENZYME CORPORATION ($3,050) |
| 2022 | $48,397 | 8 | Chiesi USA, Inc. ($27,120) |
| 2021 | $10,260 | 4 | GENZYME CORPORATION ($8,974) |
| 2020 | $10,366 | 13 | GENZYME CORPORATION ($9,016) |
| 2019 | $29,734 | 35 | GENZYME CORPORATION ($22,567) |
| 2018 | $37,238 | 48 | GENZYME CORPORATION ($33,502) |
| 2017 | $34,387 | 30 | GENZYME CORPORATION ($33,793) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/26/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $2,548.00 | General |
| 07/31/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | — | In-kind items and services | $1,250.00 | Research |
| Study: Fabry Disease Registry Protocol • Category: Genetic Disease | ||||||
| 04/03/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| Category: Genetic Disease | ||||||
| 11/09/2022 | Chiesi USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $15,255.00 | General |
| 10/13/2022 | Chiesi USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $11,865.00 | General |
| 09/28/2022 | GENZYME CORPORATION | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,425.00 | General |
| 06/02/2022 | GENZYME CORPORATION | FABRAZYME (Biological) | Consulting Fee | Cash or cash equivalent | $2,284.00 | General |
| Category: Genetic Disease | ||||||
| 04/28/2022 | GENZYME CORPORATION | FABRAZYME (Biological) | Consulting Fee | Cash or cash equivalent | $5,138.00 | General |
| Category: Genetic Disease | ||||||
| 04/11/2022 | GENZYME CORPORATION | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,536.50 | General |
| 03/31/2022 | GENZYME CORPORATION | FABRAZYME (Biological) | Consulting Fee | Cash or cash equivalent | $2,284.00 | General |
| Category: Genetic Disease | ||||||
| 01/13/2022 | GENZYME CORPORATION | FABRAZYME (Biological) | Consulting Fee | Cash or cash equivalent | $4,609.00 | General |
| Category: Genetic Disease | ||||||
| 12/01/2021 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $3,216.00 | General |
| 09/22/2021 | SANOFI-AVENTIS U.S. LLC | FABRAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,286.00 | General |
| Category: Genetic Disease | ||||||
| 05/04/2021 | GENZYME CORPORATION | FABRAZYME (Biological) | Consulting Fee | Cash or cash equivalent | $4,501.00 | General |
| Category: Genetic Disease | ||||||
| 03/06/2021 | GENZYME CORPORATION | FABRAZYME (Biological) | Consulting Fee | Cash or cash equivalent | $1,257.00 | General |
| Category: Genetic Disease | ||||||
| 11/02/2020 | GENZYME CORPORATION | FABRAZYME (Biological) | Consulting Fee | Cash or cash equivalent | $2,305.00 | General |
| Category: Genetic Disease | ||||||
| 03/23/2020 | SANOFI US SERVICES INC. | — | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| 03/13/2020 | BIOVERATIV THERAPEUTICS INC. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 02/10/2020 | GENZYME CORPORATION | FABRAZYME (Biological) | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| Category: Genetic Disease | ||||||
| 02/10/2020 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $59.38 | General |
| Category: Genetic Disease | ||||||
| 02/10/2020 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | Cash or cash equivalent | $51.12 | General |
| Category: Genetic Disease | ||||||
| 02/10/2020 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $41.71 | General |
| Category: Genetic Disease | ||||||
| 02/10/2020 | GENZYME CORPORATION | FABRAZYME (Biological) | Travel and Lodging | Cash or cash equivalent | $27.00 | General |
| Category: Genetic Disease | ||||||
| 02/10/2020 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Genetic Disease | ||||||
| 02/09/2020 | GENZYME CORPORATION | FABRAZYME (Biological) | Consulting Fee | Cash or cash equivalent | $4,800.00 | General |
| Category: Genetic Disease | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Fabry Disease Registry Protocol | GENZYME CORPORATION | $1,250 | 1 |
| Fabry Disease Registry | GENZYME CORPORATION | $469.41 | 2 |
About Dr. Sheldon Mauer, MD
Dr. Sheldon Mauer, MD is a Pediatrics healthcare provider based in Minneapolis, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174607436.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sheldon Mauer, MD has received a total of $175,979 in payments from pharmaceutical and medical device companies, with $2,548 received in 2024. These payments were reported across 141 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($134,160).
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Nephrology
- Location Minneapolis, MN
- Active Since 10/24/2006
- Last Updated 10/26/2012
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1174607436
Products in Payments
- FABRAZYME (Drug) $75,680
- FABRAZYME (Biological) $33,425
- DISEASE STATE (Drug) $13,890
- NO PRODUCT DISCUSSED (Drug) $6,111
- FABRY-DISEASE (Drug) $102.49
- GZ402671 (Drug) $10.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Minneapolis
Dr. Bruce Blazar, M.d, M.D
Pediatrics — Payments: $1.1M
Pediatrics $1.1M
Bradley Miller, M.d, M.D
Pediatrics — Payments: $567,210
Pediatrics $567,210
Kyriakie Sarafoglou, Md, MD
Pediatrics — Payments: $368,453
Pediatrics $368,453
Heather Stefanski, Md, Ph.d, MD, PH.D
Pediatrics — Payments: $159,475
Pediatrics $159,475
Antoinette Moran, M.d, M.D
Pediatrics — Payments: $98,422
Pediatrics $98,422
Kiran Belani, Mbbs Md, MBBS MD
Pediatrics — Payments: $66,261
Pediatrics $66,261